HAEMOTOLOGY ONCOLOGY

Jul 03, 2020

E. G. Garcia et.al. conducted a study to identify protein tyrosine phosphatase type 4 A3 (PRL3) as a collaborating oncogenic driver in T-cell acute lymphoblastic leukemia. The researchers…

Jul 03, 2020

A. Kuendgen et.al. conducted a study to assess if applying the WHO classification for p-myelodysplastic syndromes successfully predicts time to transformation and survival. The researchers…

Jul 02, 2020

Ying Wang et.al. conducted a study in 70 subjects with advanced B-cell cancers receiving CAR-T-cell therapy, 12 of whom had chronic HBV-infection (HBsAg positive) and 29 with resolved HBV-…

Jul 02, 2020

Kylee J. Veazey et.al. conducted a study to assess the effect of CARM1 inhibition in reducing histone acetyltransferase activity that causes synthetic lethality in CREBBP/EP300-mutated…

Jul 01, 2020

Hildo C. Lantermans et.al. conducted a study to assess that the SRC-family tyrosine kinase hematopoietic cell kinase, which is primarily expressed in the hematopoietic lineage but not in mature B…

Jul 01, 2020

At about 18 months' follow-up in treatment-naive acute myelogenous leukemia (AML) patients who were 75 years or older or otherwise unfit for intensive chemotherapy, median overall survival (OS)…

Jul 01, 2020

At about 18 months' follow-up in treatment-naive acute myelogenous leukemia (AML) patients who were 75 years or older or otherwise unfit for intensive chemotherapy, median overall survival (OS)…

Jun 30, 2020

Gauri Deb et.al. conducted a study to identify genes and cellular pathways that collaborate with LSD1 to maintain the leukaemic phenotype, and which could be targeted by combination therapies, the…